規制性SNPは,新しい転写プロモーターを作成することによって,ヒトの遺伝疾患を引き起こす
Marco De Gobbi1, Vip Viprakasit, Jim R Hughes
1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
まとめ
研究者らは,珍しい遺伝性血液疾患であるアルファタラセミアを引き起こす新しい遺伝的メカニズムを発見した. 単一の規制DNAの変化は,アルファグロービン遺伝子の正常な機能を妨げ,遺伝疾患の洞察を提供します.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- 血液学 ヘマトロジ
背景:
- アルファタラセミアは,ヘモグロビン産生に影響を与える遺伝性血液疾患です.
- 以前の研究では,染色体16に変異形態が局所化したが,分子原因は不明のままだった.
- 従来の方法は,影響を受けたメラネジア人の集団の欠陥を特定できませんでした.
研究 の 目的:
- 変種アルファタラセミアの病原遺伝的メカニズムを解明する.
- 障害の原因となる特定の分子欠陥を特定する.
- 機能的調節性単核性多形態体 (rSNP) の識別のための戦略を開発する.
主な方法:
- メラネジア人の集団における関連研究.
- アルファ・グロービン遺伝子クラスター領域の再シーケンシング.
- クロマチン免疫プレシピテーション (ChIP) アッセイ.
- タイルされたオリゴヌクレオチド配列を用いた表現分析.
主要な成果:
- ゲイン・オブ・ファンクション・レギュレーション・シングル・ヌクレオチド・ポリモルフィズム (rSNP) が特定されました.
- rSNPは,アルファグロービン遺伝子の上流にある非遺伝子領域に位置しています.
- このrSNPは,下流アルファ型グロービン遺伝子の活性化を妨害する新しいプロモーターのような要素を生み出します.
結論:
- 特定されたrSNPは,アルファタラセミアの新たな病原遺伝的メカニズムを表しています.
- この発見は,機能的なrSNPと中立のrSNPを区別するための方法を提供します.
- 発見されたメカニズムは,他の遺伝疾患にも寄与する可能性がある.
関連する概念動画
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Genome Copying Errors
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...


